Results 151 to 160 of about 36,803 (257)

Correction: Time course change of the insulin requirements during the perioperative period in hepatectomy and pancreatectomy by using an artificial pancreas STG-55. [PDF]

Diabetol Int, 2023
Teshigawara S, Tone A, Katayama A, Imai Y, Tahara T, Senoo M, Watanabe S, Kaneto M, Shimomura Y, Yagi C, Kajioka H, Kojima T, Niguma T, Nakatou T.   +13 more
europepmc   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz, Marina Farah, Laura Silveira‐Moriyama   +2 more
wiley   +1 more source

Integrating Multiple Inputs Into an Artificial Pancreas System: Narrative Literature Review. [PDF]

JMIR Diabetes, 2022
Hettiarachchi C, Daskalaki E, Desborough J, Nolan CJ, O'Neal D, Suominen H.   +5 more
europepmc   +1 more source

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

Medicinal Research Reviews, EarlyView.
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood, Jacinta R. Macdonald, Christian Anzenhofer, Tina S. Skinner‐Adams, Robert C. Reid, Thomas Kurz, David P. Fairlie, Katherine T. Andrews   +7 more
wiley   +1 more source

Glucose control during 3-month treatment with bihormonal artificial pancreas versus current diabetes care in patients after total pancreatectomy: study protocol for the PANORAMA randomized crossover trial. [PDF]

BJS Open
Leseman CA, van Veldhuisen CL, Rompen IF, Bouwense SA, Bosscha K, Busch OR, Dijkgraaf MGW, van Eijck CHJ, de Haan JS, Haen R, de Hingh IHJ, de Meijer V, Nijkamp MW, Mieog JSD, Molenaar IQ, van Santvoort HC, Stommel MWJ, Voermans RP, Wilmink JW, De Vries JH, Besselink MG.   +20 more
europepmc   +1 more source

Zero‐Shot Self‐Supervised Learning of Single Breath‐Hold Magnetic Resonance Cholangiopancreatography (MRCP) Reconstruction

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To investigate the feasibility of zero‐shot self‐supervised learning reconstruction for reducing breath‐hold times in magnetic resonance cholangiopancreatography (MRCP). Methods Breath‐hold MRCP was acquired from 11 healthy volunteers on 3T scanners using an incoherent k‐space sampling pattern, leading to a 14‐s acquisition time and an
Jinho Kim, Marcel Dominik Nickel, Florian Knoll   +2 more
wiley   +1 more source

Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study. [PDF]

Ther Adv Endocrinol Metab
Wang Q, Li X, Zhang W, Wang H, Tang J, Ding Y, Zheng X, Luo S.   +7 more
europepmc   +1 more source

Respiratory Motion Management in Abdominal MRI: Revisiting the Gap Between Technical Advances and Clinical Translation

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT The inherently slow acquisition speed of MRI makes abdominal imaging highly sensitive to respiratory motion artifacts. Since the early days of MRI, the development of respiratory motion compensation techniques has been an active research topic, and this field has seen substantial progress.
Li Feng, Hersh Chandarana
wiley   +1 more source

Effective blood glucose control in Chinese children with type 1 diabetes via a do-it-yourself artificial pancreas system: a single-center study. [PDF]

Ther Adv Endocrinol Metab
Yang L, Xie F, Han L, You F, Wei Z, Liu C, Xu C, Sun Y.   +7 more
europepmc   +1 more source

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source